Adjuvant treatment with a dialyzable leukocytes extract contributes to maintain HPV-infected women free of low-grade cervical lesions

Eur J Gynaecol Oncol. 2015;36(6):655-61.

Abstract

Purpose of investigation: To investigate if adjuvant treatment with a dialyzable extract of leukocytes (DLE), may help HPV-infected patients with low-grade intraepithelial squamous cervical lesions (LIS) to get free of HPV infection and cervical lesions.

Materials and methods: Patients with untreated, low-grade cervical lesions were treated either with surgery (Group A) or with DLE (Group B). Pa- tients with low-grade but recurrent cervical lesions were newly treated with surgery plus DLE (Group C).

Results: A decreased or ab- sent cervical lesion correlated with a diminished or absent HPV viral load at one year of treatment (r = 0.6,p <0.05). Seventy-nine percent of Group B but only 50 % of Group C and 38 % of Group A patients were free of cervical lesion after 24 months of treatment (p < 0.05).

Conclusion: The present data support the benefit of adding DLE as adjuvant for treating HPV-infected women with LIS.

MeSH terms

  • Adolescent
  • Adult
  • Cell Extracts / therapeutic use*
  • Dialysis
  • Female
  • Humans
  • Leukocytes / physiology*
  • Middle Aged
  • Papillomavirus Infections / therapy*
  • Uterine Cervical Dysplasia / prevention & control*
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / prevention & control*
  • Uterine Cervical Neoplasms / virology
  • Viral Load

Substances

  • Cell Extracts